Claims:I/WE CLAIM

1. An automated and digitalized Internet of Things based insulin injecting pen with Dual cartridges comprises of a display unit, a cloud server, a battery, a needle, Dual Cartridges, a gear box, rotators, processing control unit and a motor or actuator.

2. As claimed in claim 1, the device includes a battery, wherein the battery may be a rechargeable battery. Once the device is turned on using the power button the battery will supply energy to the device to carry on its operations.

3. As claimed in claim 1, the device includes a needle, wherein the needle is a replaceable one and it can be changed from time to time. The information regarding the insertion of the needle into the pen will be saved so that the user will know when he/she had inserted the needle and duration it has been on pen.

4. As claimed in claim 1, the device has a display unit, wherein the display unit is a touch screen.

5. As claimed in claim 4, the device has a touch screen display to carry out the setting operations, the dosage of insulin from each cartridge is set using the touch screen and the specified amount of insulin will be loaded into the syringe.

6. As claimed in claim 1, the device includes rotators to support the rotational movement of the cartridges. Whenever the user enters the value of insulin to be drawn from each cartridge, the rotators of respective cartridges will rotate to deliver the specified amount of insulin to the syringe.

7. As Claimed in claim 1, the device has an actuator or a motor to support the functioning of rotators. Also the gear box mechanism will help for smooth functioning of motor and rotators of respective cartridges.

8. As claimed in claim 1, the device has a processing unit to carry the smooth functioning of digitalized and automated insulin injecting pen.

9. As claimed in claim 3, the information regarding the needle, the amount of insulin in each of the cartridges, the refilled date and time of each cartridge, their next refill date and much more information associated with the insulin injecting pen will be saved on the cloud server.

, Description:[0002] Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.

[0003] The pervasiveness of diabetes in India has remained at 11.8% in the last four years according to a national survey. Diabetes is one of the most talked diseases in India and also the fact is that India has more people with type 2 diabetes. Also the numbers of patients who are dependent on insulin are high too.

[0004] Though a variety of Insulin Injecting pens exist, they come with disadvantages that have to be overcome by research and inventions. Insulin injecting pens are mostly used by elderly persons. Also we know very well that vision will be blurred for diabetes patient when they are suffering from diabetes for a long time. In the existing pens the patient has to voluntarily set the amount of dosage that has to be injected per prick. It is very difficult to set the dosage manually for the persons to set the dosage with bare eyes. Even though supported by spectacles there are chances that the amount of insulin injected will vary slightly from prick to prick. Sometimes there are also chances for missing dosages because of absent mind or amnesia.

[0005] A number of different types of system and methods are available for vehicle analysis and alert system regarding the condition of the vehicle in the prior art. For example, the following patents are provided for their supportive teachings and are all incorporated by reference.

[0006] In this disclosure, 201947047459: INJECTION PEN relates to an injection pen comprises a starting mechanism and a driving mechanism. A needle pin of the starting mechanism fitted to a connecting rod and a front spring is disposed in a front housing and an inner casing therein. A front cover is disposed at the front end of the front housing and covers the needle pin. A rear housing of the driving mechanism and a driving casing therein are connected to the front housing. A trigger tube and a key panel are mounted in the driving casing. A push rod fitted to a rear spring is mounted in the trigger tube. An elastic baffle of the driving casing fastens the driving casing and the push Rod and locks the rear spring. An injection needle group can be mounted between the starting mechanism and the driving mechanism. When the front cover is removed, the needle pin can be pressed and inwards retreated into the front housing to make a needle to be exposed, and the inwards retreated needle pin drives the connecting rod to push away the elastic baffle of the driving casing to perform unlocking. The released rear spring pushes the push rod to make an injection needle group to transfer a drug. After the injection, the needle pin is reset under the push of the front spring, and the needle pin is fastened in the inner casing when a key panel is pulled out by means of the connecting rod, so that the needle pin cannot be pressed to inwards retreat, and accordingly, a used syringe needle is protected, so as to prevent users from being hurt by the needle by accident.

[0007] In yet another disclosure 201917041100 AUTOMATIC FLUID PRODUCT INJECTION DEVICE: Automatic fluid product injection device comprising a body attached to a holder intended to contact a region to be injected said body containing one or more fluid product reservoirs each containing an injection plunger a needle assembly having an injection needle for penetrating into the region to be injected and an injection mechanism said needle assembly comprising an injection needle for penetrating into the region to be injected and a shape memory alloy insertion actuator wherein the injection mechanism comprises a retraction ring a needle holder an insertion ring a retraction spring an actuating ring and an insertion spring the insertion spring and the retraction spring being at rest kept in a compressed state by respective locking means and wherein the actuation of the actuator via heating such that it reaches about 50% of the possible contraction causes the actuating ring to move relative to the insertion ring to which one end of the actuator is attached said movement causing the release of the needle holder thereby extending the insertion spring which causes the needle holder and the injection needle to penetrate into the region to be injected and the actuation of the actuator via heating such that it reaches 100% of the possible contraction causes the actuating ring to move relative to the retraction ring said movement causing the release of the insertion ring and of the assembly composed of the needle holder and the injection needle such that the retraction spring retracts the injection needle out of the region to be injected.

[0008] In yet another disclosure 2884/MUM/2013 INSULIN PEN WITH UNIQUE DUEL CHEMBER DISPENSING/OPERATING SYSTEM The present invention is directed to a dual chamber cartridge retainer mechanism suitable for medication delivery pens. The cartridge retainer mechanism is made of two chambers including an inner chamber tubular body surrounding the barrel of the cartridge and outer chamber supporting engaging inner chamber that defines and works as Cartridge retainer. The plunger mounting at surrounding the back side of the outer chamber includes a rim extending from its proximal end that is diametrically dimensioned to closely engage the outer chamber syringe piston.

[0009] In yet another disclosure 1819/DELNP/2013 INTEGRATED GLUCOSE MONITOR AND INSULIN INJECTION PEN WITH AUTOMATIC EMERGENCY NOTIFICATION A portable insulin injection pen and blood glucose monitoring device is integrated into a single unit for testing and treating diabetes symptoms. The device has a housing of a size suitable for transport in a user s clothing pocket or handbag. Within the housing is a blood glucose monitoring system for receiving a sample of the user s blood and detecting its glucose level an insulin injection mechanism for administering an insulin injection and a microprocessor that calculates an insulin dosage appropriate to the detected blood glucose level and sets the insulin injection mechanism to administer the calculated insulin dosage. A communication device automatically informs a remote emergency service provider such as 911 or an emergency service to which the user has subscribed if the microprocessor determines that the detected blood glucose level presents a potential danger to the user. The microprocessor also calculates treatment regimens specific to a particular user based on the detected blood glucose level and displays the treatment regimens on an LCD display. In a particularly advantageous embodiment a GPS receiver within the housing detects the location of the device and the communication device which can be a cellular telephone separate from the housing connected wirelessly to the unit via a Bluetooth connection or cellular telephone circuitry within the housing itself transmits information regarding the location to the remote emergency service.

[0010] In yet another disclosure US20190184092 PEN CAP FOR INSULIN INJECTION PENS AND ASSOCIATED METHODS AND SYSTEMS One or more embodiments of the disclosure relate, generally, to a pen cap for a manual insulin delivery device. Such a pen cap may include a wireless communication interface, a detection circuit, a user interface, and a processor and memory. The detection circuit may be configured to detect capping and de capping of the pen cap from a manual insulin delivery device. Timing information and recommendations related to capping and de capping of the pen cap may be presented to a user.

[0011] In yet another disclosure WO2009092388 ECONOMICAL INSULIN INJECTION PEN Economical insulin injection pen that works with all types of insulin ampoules that are injected by such syringes of insulin injection where we could mix two types of insulin in addition it works with all containers (vials)of imported insulin designed for other types of pen. It can be maintained easily, who’s with the possibility of replacing Any damaged part. Moreover it is equipped with different parts and needles (9) to alleviate pain plus the new method to insert the need to the patient body without any pain besides reducing the required time to complete the injection process. The economical insulin injection pen can be accommodated for children and elder people with all types of insulin since his length starts from 3 cm. it is useful and practical for daily use as it is sterilized filled and adjusted every time it is used.

[0012] In yet another disclosure AU2015100005 Diabetic Connect Bluetooth Adaptor : The invention is an electronic device (1), also referred to as a diabetic connect Bluetooth adaptor, that facilitates the transfer of data from medical devices (5) to Bluetooth 4.0 enabled mobile and smart devices running the Diabetic plus mobile diabetes management app. The device (1) comprises of component (2), which is a Bluetooth low energy (BLE) module that provides wireless connectivity with Bluetooth 4.0 enabled devices. Component (3) is a USB host controller or chipset, which hosts the USB drivers that facilitates the transfer of data from medical devices attached to the adaptor, to any Bluetooth enabled devices paired with the adaptor. Component (4) is a replaceable battery that powers the device. Component (6) is a 2.5mm/3.5mm male jack connector or a mini/micro male USB connector for connecting the adaptor to external medical devices (5). The connector is built-in to the adaptor and can be flipped open to connect the adaptor to the medical device. The medical devices include digital insulin pens such as the Smart plus digital insulin pen and approved glucose meters. External devices (8) and (9) represent Bluetooth enabled mobile devices such as the Apple iPhone, iPad, Android phone, smart devices and tablets. The components (2), (3), (4), and (6) are housed in a container (1) (preferably made of plastic or metallic material) of approximately 4cm x 2cm x lcm in dimension. Component (11) is an LED display for displaying device status information to the user and (10) is an ON/OFF power button. Figure 1 and Figure 2 are suggested drawings to accompany the abstract.
[0013]
[0013] In yet another disclosure US20110313349 Medical module for drug delivery pen: Various embodiments of a medical module are provided which includes primary module housing, a secondary module housing, a dosage sensor, a power source, and a microcontroller. The module is configured to be attached to a disposable drug delivery pen or a reusable drug delivery pen so that the module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or re usage of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module.

[0014] In yet another disclosure US20120004637 Drug delivery management systems and methods: Various embodiments of a “smart” drug delivery system are provided which includes an add-on module and a reusable or disposable drug pen in conjunction with a data management unit(s) DMU. Upon attachment to the pen, the add-on module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reuse of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module. Methods of using the drug delivery system are also described.

[0015] In yet another disclosure US20170232204 IMPROVED SYSTEMS AND METHODS FOR MEDICINE DELIVERY Improved systems and methods for medicine delivery, and in particular, improved insulin pen needles and related devices are provided. Smart injection devices record and transfer data including medicine level, delivered dose, dose confirmation, and dose time and date. Additional data captured may include glucose concentration, insulin level, carbohydrates ingested, stress level, exercise, blood pressure, and glucose high and low excursion events. Various means of data collection and analysis are provided and systems can identify and flag patients who require intervention. Smart sleeves and add sensing capability to standard insulin pens. Pen needles are provided with sensing capability to confirm and measure doses delivered by insulin pen. A two-part pen cap include a primary sleeve that connects to the insulin pen and an end cap that provides for capturing the time of dose delivery, and monitoring the hold time for a dose delivery after plunger movement.

[0016] In yet another disclosure WO2016019192 PCT/US2015/043005: CONTINUOUS GLUCOSE MONITORING INJECTION DEVICE An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

[0017] In yet another disclosure US20190348165 INTELLIGENT MEDICATION DELIVERY SYSTEMS AND METHODS USING A PRESCRIPTION-REGULATED SOFTWARE APPLICATION Systems, devices and methods are disclosed for a prescription-regulated software application and an associated medical device. In some aspects, a smart medicine-injection device (e.g., smart insulin pen) is configured to be in communication with a patient's companion device (e.g., smartphone) having a software application (prescription app) that serves the patient as a complimentary medical device to the smart medicine-injection device, in which only certain features and functionalities of the prescription app are fully operable based on device pairing with the smart medicine-injection device to unlock medical device capabilities only available to the patient through prescription.

[0018] Thus there remains a constant need to design and implement an Internet of Things based automated insulin injecting pen with dual cartridge. The proposed invention relates to an automated and digitalized insulin pen which will help the elderly persons or any patient regardless of age factor to select the exact amount of dosages by touching the display screen which is present in the insulin pen. The important factor of the invention is the dual cartridge since the user can have two varieties of insulin in a single pen and prick. Also there is an alert message system which will be connected to the mobile phone of the care taker. The quantity of medicine remaining in the cartridges will also be sent as an message. All the information from the insulin pen is stored on a cloud server for further references as well as to generate reports on the usage.

[0019] The above information is presented as background information only to assist with an understanding of the present disclosure. No determination has been made, no assertion is made, and as to whether any of the above might be applicable as prior art with regard to the present invention.

[0020] In the view of the foregoing disadvantages inherent in the known types of various Insulin Injecting Pens now present in the prior art, the present invention provides an Improved and efficient Internet of things based Insulin Injecting pen with Dual cartridge. As such, the general purpose of the present invention, which will be described subsequently in greater detail, is to provide a new and improved Automated and digitalized insulin injecting pen which has all the advantages of the prior art and none of the disadvantages.
SUMMARY OF THE INVENTION

[0021] In the view of the foregoing disadvantages inherent in the known types of Insulin injecting pens now present in the prior art, the present invention provides an improved automated and digitalized Insulin injecting pen with dual cartridge. As such, the general purpose of the present invention, which will be described subsequently in greater detail, is to provide a new and improved Internet of Things based Insulin injecting pen which has all the advantages of the prior art and none of the disadvantages.

[0022] The main objective of the proposed invention is to develop an Internet of Things based Insulin injecting pen with a dual cartridge. Also the proposed insulin device is digitalized with a digital display touch screen and the entire operation of the insulin injecting pen is automated.

[0023] Another objective of the invention is that the Insulin injecting pen has a dual cartridge and also be designed to accommodate plurality of cartridges. Dual cartridge is essential feature when two types of insulin are advised by the doctor. Two types of insulin advised will be mixed accordingly and injected to the patient in one shot.

[0024] Yet another object of the invention is that the device or insulin injecting pen has a digital display unit. The display unit is a touch screen which has options to choose the amount of dosage from both the cartridges.

[0025] Yet another object of the invention is that the device has a time sensor which will record the timings of each shot and save the data regarding the same on the cloud server.

[0026] Yet another object of the invention is that the device or insulin injecting pen has a reset button to reset the functionalities of the pen when the cartridges are reloaded.

[0027] Another objective of the invention is that the amount of insulin injected per shot will be accurate and not appropriate. Whereas in the existing pens where the patient has to set the dosage manually and obviously there will slightly higher or lower dosage of insulin.

[0028] Yet another object of the invention is that, there is also an alert message mechanism which will send an alert message to the care taker of the patient along with an alert tone from the device or insulin injecting pen itself. Thus there will be skipping of medication. The care taker need not have to be around the patient all the time to remind them regarding the medication.

[0029] Yet another object of the invention is that the cartridges are supported by rotators. Whenever the patient sets the dosage using the display screen, the respective rotators will start their rotation to load the particular amount of insulin into the syringe.

[0030] Yet another object of the invention is that the rotators of the cartridge are supported by a motor along with a gear box mechanism. This will pave way for smooth functioning of cartridges and load the syringe with respective types of insulin medication.

[0031] Yet another object of the invention is that the device also has an option to send alert messages regarding the amount of insulin left over in each of the cartridges and an alert regarding the day and date the cartridge will get empty. The information regarding their expiry, date of refilling, date of next refilling date will be stored in the device as well as the cloud server.

[0032] In this respect, before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and to the arrangements of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced and carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein are for the purpose of description and should not be regarded as limiting.

[0033] These together with other objects of the invention, along with the various features of novelty which characterize the invention, are pointed out with particularity in the disclosure. For a better understanding of the invention, its operating advantages and the specific objects attained by its uses, reference should be had to the accompanying drawings and descriptive matter in which there are illustrated preferred embodiments of the invention.

BRIEF DESCRIPTION OF DRAWINGS

[0034] The invention will be better understood and objects other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such description makes reference to the annexed drawings wherein

[0035] Fig 1 illustrates the Schematic view of the dual Cartridge insulin injecting pen according to an embodiment herein.

[0036] Fig 2 illustrates the Exploded view of the dual Cartridge insulin injecting pen according to an embodiment herein.

[0037] Fig 3 illustrates the Flow diagram of the dual Cartridge insulin injecting pen according to an embodiment herein.

DETAILED DESCRIPTION OF THE INVENTION

[0038] In the following detailed description, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that the embodiments may be combined, or that other embodiments may be utilized and that structural and logical changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.

[0039] While the present invention is described herein by way of example using several embodiments and illustrative drawings, those skilled in the art will recognize that the invention is neither intended to be limited to the embodiments of drawing or drawings described, nor intended to represent the scale of the various components. Further, some components that may form a part of the invention may not be illustrated in certain figures, for ease of illustration, and such omissions do not limit the embodiments outlined in any way. It should be understood that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the invention covers all modification/s, equivalents and alternatives falling within the spirit and scope of the present invention as defined by the appended claims. The headings are used for organizational purposes only and are not meant to limit the scope of the description or the claims. As used throughout this description, the word "may" is used in a permissive sense (i.e. meaning having the potential to), rather than the mandatory sense (i.e. meaning must). Further, the words "a" or "an" mean "at least one” and the word “plurality” means one or more, unless otherwise mentioned. Furthermore, the terminology and phraseology used herein is solely used for descriptive purposes and should not be construed as limiting in scope. Language such as "including," "comprising," "having," "containing," or "involving," and variations thereof, is intended to be broad and encompass the subject matter listed thereafter, equivalents, and any additional subject matter not recited, and is not intended to exclude any other additives, components, integers or steps. Likewise, the term "comprising" is considered synonymous with the terms "including" or "containing" for applicable legal purposes. Any discussion of documents, acts, materials, devices, articles and the like is included in the specification solely for the purpose of providing a context for the present invention.

[0040] In this disclosure, whenever an element or a group of elements is preceded with the transitional phrase "comprising", it is understood that we also contemplate the same element or group of elements with transitional phrases "consisting essentially of, "consisting", "selected from the group consisting of”, "including", or "is" preceding the recitation of the element or group of elements and vice versa.

[0041] The proposed invention is an automated and digitalized Internet of things based Insulin injecting pen along with space for dual cartridges. Most of the people who will use the insulin injecting pen will be either aged or have blurred vision which is one of the side effects of diabetes. Thus it is difficult for them to load the syringe with exact amount of insulin as per the advice of the doctor for each shot.

[0042] In the present device, the insulin pen is digitalized with a display screen to carry out the operations of loading the syringe with specified amount of insulin. The display screen is a touch screen and the patient has to just enter the value of insulin to be loaded into syringe in milliliters. The invention is perfect solution for loading the exact amount of insulin rather than loading the syringe manually. So the patient can be hassle free and be relaxed that they have taken exact dosage of insulin for each and every shot as per the doctor’s advice.

[0043] The dual cartridge is an essential feature when doctors advice for dosage of two types of insulin that has to taken at one shot. Thus the patient just has to do the settings using the touch screen. Both the cartridges are rotated using the rotator and the exact combinations of both the types of insulin are loaded into the syringe. There is also an option to load both the cartridges with the same type of insulin and use it one by one. Here the advantage is to use the pen for longer time without the head ache of refilling it within short span of time.

[0044] The device also has options for gathering all the important aspects of the insulin pen. It is essential to change the needle also from time to time. Thus the device the date and day the needle is inserted along with the date and day it has to be replaced with a newer one. Also the information regarding the date when the cartridges were refilled, their expiry date, the approximate date on which they may be empty and such. These data will be stored on a cloud server for future references and report analysis.

[0045] Reference will now be made in detail to the exemplary embodiment of the present disclosure. Before describing the detailed embodiments that are in accordance with the present disclosure, it should be observed that the embodiment resides primarily in combinations arrangement of the system according to an embodiment herein and as exemplified in FIG. 1.

[0046] Figure 1 illustrates the schematic view of the insulin injecting pen. The Insulin injecting pen is device 100. The device 100 has a needle 101 which is replaceable from time to time. The device 100 will be switched on using the power button 102. After switching on the device 100 using the power button 102, the setting button 103 has to be pressed to do the reset operations associated with the device 100. The device 100 can be operated in both the modes that are both manual and automatic mode. The cartridges 106a and 106b will fill in their respective dosages in the canal 104a and 104b respectively. The cartridges are rotated to load the syringe with the specified amount of insulin using the rotators 107a and 107b respectively. The rotators 107a and 107b are supported by the motor or actuator 109. The entire cartridge mechanism includes a gear box 108 for smooth functioning of the device 100. 110 is the control unit or processing unit. The processing unit 110 also encloses a Bluetooth for communicating with the cloud server 111.

[0047] Figure 2 illustrates the exploded view of the insulin injecting pen. The device 100 has a display unit 105 is touch screen that will allow the user to set the dosages of the cartridges 106a and 106b. The reset button 103 will act on cartridges 106a and 106b respectively in manual mode.

[0048] Figure 3 illustrates the flow diagram of the insulin injecting pen that is device 100. The patient or the care taker of the user will switch on the device 100 using power button 102 and set their input values given to the cartridges for loading into the syringe. The display unit 105 is connected to the time sensor as well as the cloud server 111. The cartridges 106a and 106b will act according to the input from display unit 105 or reset button 103. If the cartridge is empty or about to get empty, an alert message will be sent to the user regarding the reloading of the cartridge 106a or cartridge 106b or both. The syringe is loaded from both the cartridges and finally to the needle 101. The information regarding the date when cartridge’s refilled, their next due date and such information will be saved on the cloud server 111.